This inventor holds 1 USPTO granted patent. Top assignee: University of Iowa Research Foundation. Active years: 2001.
Company Filing History:
Years Active: 2001
Title: The Innovative Contributions of Connie Lebakken
Introduction
Connie Lebakken is a notable inventor based in Iowa City, IA (US). He has made significant contributions to the field of biomedical research, particularly in the study of metabolic disorders. His work has implications for understanding and treating conditions associated with sarcospan mutations.
Latest Patents
Connie Lebakken holds a patent for a transgenic knockout mouse model, specifically designed to study clinical disorders associated with sarcospan mutations. The patent, titled "Sarcospan-deficient mouse as a model for clinical disorders associated with sarcospan mutations," describes a mouse whose genome has a homozygous disruption in its endogenous sarcospan gene. This disruption prevents the synthesis of functional sarcospan in the cells of the mouse. The resulting mouse exhibits significantly larger epididymal fat pad deposits, ranging from 1.4 to 6.8 times larger than those of a wild-type mouse. The patent also outlines methods for producing this mouse and describes cells derived from it. This model can be utilized to identify therapeutic agents for individuals diagnosed with metabolic disorders linked to a reduction or loss of expression of wild-type sarcospan, such as weight gain.
Career Highlights
Connie Lebakken is affiliated with the University of Iowa Research Foundation, where he continues to advance his research. His innovative work has garnered attention in the scientific community, contributing to a deeper understanding of metabolic disorders and potential therapeutic approaches.
Collaborations
Some of his notable coworkers include Kevin P Campbell and Rachelle Crosbie, who have collaborated with him on various research projects. Their combined expertise enhances the impact of their research efforts.
Conclusion
Connie Lebakken's contributions to the field of biomedical research, particularly through his innovative patent, highlight the importance of developing models for studying complex metabolic disorders. His work at the University of Iowa Research Foundation continues to pave the way for future advancements in therapeutic strategies.